Fed up USA

Pharmaceutical Research and Manufacturers of America (PhRMA)

——
 Pharmaceutical Research and Manufacturers of America (PhRMA) [Drug Lobby]
-950 F Street, NW, Suite 300; Washington, DC 20004 Phone 202.835.3400 Fax 202.835.3414 | Web: http://www.phrma.org/
——
From http://www.phrma.org/about/phrma - The Pharmaceutical Manufacturers Association was founded in 1958. Its name was changed to the Pharmaceutical Research and Manufacturers of America in 1994 … Headquartered in Washington, D.C., PhRMA represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live “longer, healthier and more productive” lives. … PhRMA members alone invested an estimated $49.4 billion in 2010 in discovering and developing new medicines. Industry-wide research and investment reached a record $67.4 billion in 2010. … America’s biopharmaceutical research sector is the global leader in medical innovation, with more than 300 new medicines approved by the Food and Drug Administration [the laughable revolving door agency - comprised of "former" employees from the industry] in the last decade. Roughly 2,900 compounds are currently being studied in the United States — more than all other regions. … In addition to Washington, PhRMA has offices in Albany, N.Y.; Atlanta; Baton Rouge, La.; Denver; Indianapolis; Olympia, Wash.; St. Paul, Minn.; Sacramento, Calif.; Massachusetts; and Tokyo, Japan.
——
They have at least 26 members on their board; but they don’t list ’em. Here are the few names I can find, for now….and the names of current execs and boards of all their member corporations.
——
Leadership / Executives / Board
Chris Viehbacher – Chairman of the PhRMA Board
     CEO of Sanofi. Viehbacher, born 1960, holds German and Canadian nationalities. Read more.
******
John J. Castellani - President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America
    Castellani became President and Chief Executive Officer of the Pharmaceutical Research and Manufacturers of America in August 2010. Read more
Paul T. Antony – Chief Medical Officer & Director of the Office of Accountability
 Dr. Paul Antony Signs the Innovation Wall
******
Diane Bieri – Executive Vice President and General Counsel
 
******
David Brennan – CEO and Executive Director of AstraZeneca
  
******
Richard T. Clark – CEO and President of Merck
    
******
Peter R. Dolan – Bristol-Myers Squibb CEO
 
******
Jerzy Gruhn – President, Novo Nordisk Inc.
  
******
Robert Hugin – President and CEO of Celgene Corporation
 
******
Mark Iwicki - President and CEO, Sunovion Pharmaceuticals Inc.
  
******
Ken Johnson – Senior Vice President of Communications
  Prior to joining PhRMA, he held senior advisory and communications roles for the federal government, playing a key role in developing the strategic communications plan for implementation of the 9/11 Commission recommendations into law. He was also at the forefront of the much-publicized congressional “investigations” into Enron, Martha Stewart, Ford-Firestone, WorldCom, Global Crossing, Qwest, HealthSouth, Los Alamos Nuclear Laboratory, and human cloning.
******
Jeffrey Kindler – Chairman and CEO, Pfizer
   
******
John Lechleiter – Eli Lilly
   <–wife Sara.
******
Wes Metheny – PhRMA Senior Vice President
******
David Y. Norton – Johnson & Johnson Pharmaceuticals Group
 
******
Ian Read, President and Chief Executive Officer, Pfizer
 
******
Staffan Schüberg – President, Lundbeck Inc.
******
Mimi Simoneaux – Senior Vice President of External Affairs
 Mimi Simoneaux Kneuer http://undertheinfluence.nationaljournal.com/2010/04/now-that-health-care-reform.php
******
Christopher A. Singer – President of International Section
Christopher Singer http://www.linkedin.com/pub/christopher-singer/30/673/659 - Chief Global Operating Officer at United States Pharmacopeia. Past: Chief Operating Officer at Pharmaceutical Research and Manufacturers Association; COO at PhRMA; SVP Latin America at GlaxoSmithKline; Director – Federal Relations at Pfizer. Washington D.C. Metro Area.
******
Wilbert Joseph “Billy” Tauzin – CEO 2005-2010
    Former GOP Louisiana Representative.
******
Daniel Tassé – CEO, Ikaria
 
——
PhRMA Foundation Board of Directors
Garry A. Neil, M.D. – Chairman
 Corporate Vice President, Corporate Office of Science & Technology, Johnson & Johnson, Raritan, New Jersey.
******
G. Mikael Dolsten, M.D., Ph.D.
 President, BioTherapeutics Research & Development Senior Vice President, Pfizer Inc., New York, New York.
******
Ivan Gergel, M.D.
 Executive Vice President, R&D, Endo Pharmaceuticals, Chadds Ford, Pennsylvania.
******
Glenn J. Gormley, M.D., Ph.D.
 President & Chief Science Officer, Daiichi Sankyo Pharma Development, Edison, New Jersey.
******
Howard G. Hutchinson, M.D.
 Chief Medical Officer, AstraZeneca Pharmaceuticals Inc., Wilmington, Delaware.
******
Peter S. Kim, Ph.D.
 President, Merck Research Laboratories, Merck & Co., North Wales, Pennsylvania.
******
John M. Leonard, M.D.
 Vice President of Global Scientific and Medical Affairs, Abbott Laboratories, Abbott Park, Illinois.
******
Jan M. Lundberg,Ph.D.
 Executive Vice President, Science and Technology; President, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
******
John J. Orloff, M.D.
 Senior Vice President, Chief Medical Officer, Global Development, Novartis Pharma AG, East Hanover, NJ.
******
Moncef Slaoui, Ph.D.
 Chairman, Research & Development, GlaxoSmithKline, King of Prussia, Pennsylvania.
******
John Castellani
 President and Chief Executive Officer, PhRMA, Washington, DC. 
——
Member Companies
Abbott
-100 Abbott Park Road; Abbott Park, IL 60064 (847) 937-6100 (phone) (847) 937-1511 (fax)
Senior Management Team
Miles D. White – Chairman of the Board and Chief Executive Officer
Thomas C. Freyman – Executive Vice President, Finance and Chief Financial Officer
Richard W. Ashley – Executive Vice President, Corporate Development
John M. Capek, Ph.D. – Executive Vice President, Medical Devices
Richard A. Gonzalez – Executive Vice President, Pharmaceutical Products Group, President, Abbott Ventures, Inc.
John C. Landgraf – Executive Vice President, Global Nutrition
Edward L. Michael – Executive Vice President, Diagnostics
Laura J. Schumacher – Executive Vice President, General Counsel and Secretary
Carlos Alban – Senior Vice President, Proprietary Pharmaceutical Products, Global Commercial Operations
Brian J. Blaser – Senior Vice President, Diagnostics
David Forrest – Senior Vice President, International Nutrition
Stephen R. Fussell – Senior Vice President, Human Resources
Robert B. Hance – Senior Vice President, Vascular
John M. Leonard, M.D.  – Senior Vice President, Pharmaceuticals, Research and Development
Heather L. Mason – Senior Vice President, Diabetes Care
James V. Mazzo – Senior Vice President, Medical Optics
Mary T. Szela – Senior Vice President, Global Strategic Marketing and Services
Michael J. Warmuth – Senior Vice President, Established Products, Pharmaceutical Products Group
J. Scott White – Senior Vice President, U.S. Nutrition
Board of Directors
Robert J. Alpern, M.D. – Dean, Yale School of Medicine, New Haven, Connecticut
Roxanne S. Austin – President and Chief Executive Officer, Austin Investment Advisors. Newport Coast, California
W. James Farrell – Retired Chairman and Chief Executive Officer, Illinois Tool Works Inc., Glenview, Illinois
H. Laurance Fuller – Retired Co-Chairman of the Board, BP Amoco, p.l.c., London, United Kingdom
Edward M. Liddy – Partner, Clayton, Dubilier & Rice, LLC, New York, New York
Phebe N. Novakovic – Executive Vice President – Marine Systems, General Dynamics Corporation, Falls Church, Virginia
William A. Osborn – Chairman and former Chief Executive Officer, Northern Trust Corporation and its principal subsidiary, The Northern Trust Company, Chicago, Illinois
Samuel C. Scott III – Retired Chairman, President and Chief Executive Officer, Corn Products International Inc., Westchester, Illinois
Glenn F. Tilton – Chairman of the Board, United Continental Holdings, Inc. and Chariman of the Midwest Region, JPMorgan Chase & Co., Chicago, Illinois
Miles D. White – Chairman of the Board and Chief Executive Officer, Abbott
——
Alexion Pharmaceuticals, Inc.
-352 Knotter Drive; Cheshire, CT  06410 203-272-2596  (phone) 203-271-8198 (fax)
Management Team
Leonard “Lenny” Bell, M.D. - Chief Executive Officer
Stephen Squinto, Ph.D. - Executive Vice President and Head of Research & Development
Patrice Coissac – Senior Vice President, Alexion Pharmaceuticals; President, Alexion Pharma International
Clare Carmichael – SVP, Chief Human Resources Officer
Thomas Dubin - Senior Vice President and Chief Legal Officer
David Hallal – Senior Vice President, Global Commercial Operations
Vikas Sinha – Senior Vice President and Chief Financial Officer
Camille Bedrosian M.D. - Senior Vice President and Chief Medical Officer
M. Stacy Hooks, Ph.D. - Senior Vice President, Technical Operations
Claude Nicaise M.D. - Senior Vice President, Strategic Product Development & Global Regulatory Affairs
James Bilotta M.B.A. - Vice President and Chief Information Officer
Thomas Bock M.D., M.B.A. - Senior Vice President, Global Medical Affairs
Daniel Caron – Vice President, Site Operations and Engineering  
Sven Ante (Bill) Lundberg M.D. - Vice President and Head of Translational Medicine
Margaret Olinger, M.B.A – Vice President, Global Hematology Franchise
Jeremy Springhorn Ph.D. - Vice President, Corporate Strategy and Business Development
Heidi Wagner Esq. - Vice President, Global Government Affairs
Board of Directors
Leonard Bell, M.D. – Chief Executive Officer
Max Link, Ph.D. - Chairman of the Board of Directors
William Keller – Director
Joseph A. Madri, Ph.D., M.D. – Director
R. Douglas Norby - Director
Alvin S. Parven – Director
Andreas Rummelt, Ph.D. – Director
Ann Veneman – Director (served as Secretary of the U.S. Department of Agriculture (USDA) from January 2001 to January 2005.)
 UNICEF executive director and long-time lobbyist for Monsanto, etc.
—–
Alkermes, Inc.
-852 Winter Street; Waltham, MA 02451 (781) 609-6000 (phone) (781) 890-0524 (fax)
Management Team
Richard F. Pops – Chairman and Chief Executive Officer
Shane Cooke
Kathryn L. Biberstein
Dennis J. Bucceri
Madeline D. Coffin
Elliot W. Ehrich, M.D.
James M. Frates
Blair C. Jackson
Stephen King
Michael J. Landine
Rebecca J. Peterson
Gordon G. Pugh
James L. Botkin
Peter Thornton
Board of Directors
Richard F. Pops – Chairman and Chief Executive Officer
David W. Anstice – From 2006 to 2008, he served as Executive Vice President of Merck & Co., Inc.
Floyd E. Bloom, M.D. - A founder of Alkermes. Formerly of Yale University, the National Institute of Mental Health and The Salk Institute.
Robert A. Breyer – Breyer also served on the Board of Directors of Lentigen.
Wendy L. Dixon, Ph.D. 
Geraldine Henwood – was the co-founder and Chief Executive Officer of Auxilium Pharmaceuticals, Inc.
Paul J. Mitchell – Chief Financial Officer and Treasurer of Kenet, Inc. since April 2002.
Mark B. Skaletsky – Chairman, CEO and President of Trine Pharmaceuticals, Inc.
——
Amgen Inc.
-One Amgen Center Drive; Thousand Oaks, CA 91320 (805) 447-1000 (phone) (805) 447-1985 (fax)
Executive Management
Beier, David - SVP, Global Government Affairs, Communications and Philanthropy
Bonanni, Fabrizio - EVP, Operations
Bradway, Robert A. - President and COO
Daly, Jim - SVP, North America Commercial Operations 
Harper, Sean – SVP, Global Development and Corporate Chief Medical Officer 
Hoffmann, Rolf - SVP, International Commercial Operations
Hooper, Anthony - EVP, Global Commercial Operations
McKenzie, Diana - SVP and CIO
McNamee, Brian - SVP, Human Resources
Ofman, Joshua J- SVP, Global Value and Access
Perlmutter, Roger M. - EVP, Research and Development
Richo, Anna - SVP and Chief Compliance Officer
Scott, David - SVP, General Counsel and Secretary
Sharer, Kevin - Chairman of the Board and CEO
Board of Directors
Kevin W. Sharer – Chairman of the Board and CEO, Amgen Inc.
David Baltimore – President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology
Frank J. Biondi, Jr. – Senior Managing Director, WaterView Advisors LLC
Robert A. Bradway – President and COO, Amgen Inc.
François de Carbonnel – Former Chairman of the Board and Director, Thomson S.A. and Director of Corporations
Vance D. Coffman – Retired Chairman of the Board and CEO, Lockheed Martin Corporation
Rebecca M. Henderson, Ph.D – Senator John Heinz Professor of Environmental Management, Harvard Business School
Frank C. Herringer – Chairman and Retired CEO, Transamerica Corporation
Gilbert S. Omenn – Professor of Internal Medicine, Human Genetics & Public Health and Director of the Center for Computational Medicine and Bioinformatics, University of Michigan, and former CEO, University of Michigan Health System
Judith C. Pelham – President Emeritus, Trinity Health
Adm. J. Paul Reason, USN (Retired) – Former Vice Chairman and President, Metro Machine Corporation
Leonard D. Schaeffer – Chairman, Surgical Care Affiliates
Ronald D. Sugar – Chairman Emeritus, Northrop Grumman Corporation
——
Arena Pharmaceuticals, Inc.
-6166 Nancy Ridge Drive; San Diego, CA  92121 858-453-7200 (phone) 858-453-7210 (fax)
Executive Officers
Jack Lief - Co-Founder, Chairman, President and Chief Executive Officer
Dominic P. Behan, Ph.D. - Co-Founder, Director, Senior Vice President and Chief Scientific Officer
Robert E. Hoffman - Vice President, Finance and Chief Financial Officer
William R. Shanahan, Jr., M.D., J.D. - Senior Vice President and Chief Medical Officer
Steven W. Spector - Senior Vice President, General Counsel and Secretary
Board of Directors
Jack Lief -Co-Founder, Chairman, President and Chief Executive Officer
Dominic P. Behan, Ph.D. - Co-Founder, Director, Senior Vice President and Chief Scientific Officer
——
Astellas Pharma US, Inc (Japan)
-Three Parkway North; Deerfield, IL 60015 (847) 317-8800 (phone) (847) 317-5983 (fax)
Masao Yoshida – U.S. Representative Director; President and Chief Executive Officer
——
AstraZeneca Pharmaceuticals LP
-1800 Concord Pike; P.O. Box 15437 Wilmington, DE 19850 (302) 886-3000 (phone) (302) 886-2972 (fax)
Senior Executive Team
David Brennan – Executive Director & Chief Executive Officer
Simon Lowth – Executive Director & Chief Financial Officer
Tony Zook – Executive Vice President, Global Commercial
Martin Mackay – President, R&D
David Smith – Executive Vice-President, Global Operations & IS
Lynn Tetrault – Executive Vice-President, Human Resources and Corporate Affairs
Jeff Pott – General Counsel
Katarina Ageborg – Chief Compliance Officer
Board of Directors
Louis Schweitzer – Non-Executive Chairman; Chairman of the Nomination and Governance Committee, member of the Remuneration Committee.
David Brennan – Executive Director & Chief Executive Officer
Simon Lowth – Executive Director & Chief Financial Officer
Marcus Wallenberg – Non-Executive Director; Member of the Science Committee
Dame Nancy Rothwell – Non-Executive Director; Chairman of the Science Committee, member of the Remuneration Committee, member of the Nomination and Governance Committee
John Varley – Non-Executive Director; Chairman of the Remuneration Committee, member of the Nomination and Governance Committee
Michele Hooper – Senior Non-Executive Director; Member of the Audit Committee, member of the Nomination and Governance Committee
Jean-Philippe Courtois – Non-Executive Director; Member of the Audit Committee
Rudy Markham – Non-Executive Director; Member of the Audit Committee
Bruce Burlington – Non-Executive Director; Member of the Science Committee, member of the Audit Committee
Baroness Shriti Vadera – Non-Executive Director; member of the Audit Committee
——
Bayer HealthCare  LLC
-6 West Belt; Wayne, New Jersey 07470 (973) 694-4100 (phone) (973) 487-2003 (fax)
Board of Management
Dr. Marijn Dekkers – Chairman (Dutch)
Werner Baumann  – Chief Financial Officer
Prof. Dr. Wolfgang Plischke – Innovation, Technology and Environment, Asia/Pacific region
Dr. Richard Pott - Strategy and Human Resources & Labor Director
Supervisory Board
Thomas de Win - Vice-Chairman
Dr. Paul Achleitner
André Aich
Willy Beumann
Dr. Clemens Börsig
Dr.-Ing. Thomas Fischer
Peter Hausmann
Prof. Dr.-Ing. e.h. Hans-Olaf Henkel
Reiner Hoffmann
Dr. rer. pol. Klaus Kleinfeld
Petra Kronen
Dr. rer. nat. Helmut Panke
Hubertus Schmoldt
Dr.-Ing. Ekkehard D. Schulz
Dr. Klaus Sturany 
Roswitha Süßelbeck
Dipl.-Ing. Dr.-Ing. e.h. Jürgen Weber 
Prof. Dr. Dr. h.c. Ernst-Ludwig Winnacker 
Oliver Zühlke
Hermann Josef Strenger – Honorary Chairman
——
-133 Boston Post Road; Weston, MA 02493 781-464-2000 (phone) 617-679-2617 (fax)
Management
George A. Scangos, Ph.D.
Susan H. Alexander
Paul J. Clancy
John G. Cox
Steven H. Holtzman
Tony Kingsley
Douglas E. Williams, Ph.D.
Board of Directors
Mr. William D. Young (Chairman)
George A. Scangos, Ph.D.
Alexander J. Denner, Ph.D.
Ms. Caroline Dorsa
Ms. Nancy L. Leaming
Richard C. Mulligan, Ph.D.
Mr. Robert W. Pangia
Stelios Papadopoulos, Ph.D.
Mr. Brian S. Posner
Eric K. Rowinsky, M.D.
The Honorable” Lynn Schenk
Stephen A. Sherwin, M.D
——
BioMarin Pharmaceuticals, Inc.
-105 Digital Drive; Novato, CA 94949 415-506-6700 (Phone); 415-382-7889 (Fax)
Management Team
Jean-Jacques Bienaimè- Chief Executive Officer
Stephen Aselage - Executive Vice President and Chief Business Officer
Robert A. Baffi, Ph.D. - Executive Vice President, Technical Operations
Henry J. Fuchs, M.D. - Executive Vice President and Chief Medical Officer
Jeffrey H. Cooper - Senior Vice President and Chief Financial Officer
G. Eric Davis - Senior Vice President, General Counsel and Secretary
Daniel P. Maher - Senior Vice President, Product Development
Joshua A. Grass - Senior Vice President, Corporate and Business Development
Philip Lo Scalzo - Vice President, Corporate Compliance and Ethics
Ed Von Pervieux - Vice President and Chief Information Officer
Mark Wood - Vice President, Human Resources and Corporate Affairs
Board of Directors
Jean-Jacques Bienaimè - Chief Executive Officer
Kenneth Bate – President and Chief Executive Officer, Archemix, Inc.
Michael Grey – Venture Partner, Pappas Ventures; President and Chief Executive Officer, Lumena Pharmaceuticals, Inc.
Elaine Heron – Chairman and Chief Executive Officer, Amplyx Pharmaceuticals, Inc.
Pierre Lapalme – Former President and Chief Executive Officer, Ethypharm, Inc., North America
V. Bryan Lawlis – President and Chief Executive Officer, Itero Biopharmaceuticals, Inc.
Alan Lewis, Ph.D. – Chief Executive Officer and Director, Ambit Biosciences
Richard Meier – Executive Vice President and Chief Financial Officer, TeleFlex, Incorporated
William Young – Venture Partner, Clarus Venture, San Francisco and Boston
Science Advisory Board
Jeffrey Borer, M.D. - Director, The Howard Gilman Institute for Valvular Heart Diseases, Weill Medical College of Cornell University, New York, New York
Raymond C. Stevens, Ph.D. - Professor of Molecular Biology & Chemistry, The Scripps Research Institute, La Jolla, California
Alan Lewis, Ph.D. - Chief Executive Officer and Director, Ambit Biosciences
Stephen L. Hauser, M.D. - Robert A. Fishman Distinguished Professor and Chair of the Department of Neurology, UCSF
Joseph Loscalzo, M.D., Ph.D. - Chairman, Department of Medicine Brigham and Women’s Hospital, Boston, Massachusetts; Editor in Chief, Circulation
David L. Rimoin, M.D., Ph.D. - Steven Spielberg Chair and Director, Medical Genetics Institute, Director, International Skeletal Dysplasia Registry, Cedar-Sinai Medical Center, Los Angeles, California
Larry J. Shapiro, M.D. - Spencer T. and Ann W. Olin Distinguished Professor, Executive Vice Chancellor for Medical Affairs and Dean, Washington University School of Medicine, St. Louis, Missouri
——
Boehringer Ingelheim Pharmaceuticals, Inc.
-900 Ridgebury Road; Ridgefield, CT 06877 (203) 798-9988 (phone) (203) 791-6234 (fax)
Managing Directors
Dr. Andreas Barner – Chairman of the Board
Hubertus von Baumbach – Corporate Board Division Finance and Animal Health
Dr. Wolfram Carius
Engelbert Tjeenk Willink
——
Bristol-Myers Squibb Company
-345 Park Avenue; New York, NY 10154 (212) 546-4000 (phone) (212) 546-4094 (fax)
Senior Management Team
Lamberto Andreotti - Chief Executive Officer
Charles Bancroft - Executive Vice President and Chief Financial Officer
Giovanni Caforio, M.D. - President, U.S. Pharmaceuticals
Béatrice Cazala - Executive Vice President, Commercial Operations
John E. Celentano - Senior Vice President, Human Resources, Public Affairs and Philanthropy
Francis Cuss, MB BChir, FRCP – Senior Vice President, Research, R&D
Brian Daniels, M.D. - Senior Vice President, Global Development and Medical Affairs, R&D
Sandra Leung – General Counsel and Corporate Secretary
Jeremy Levin, D.Phil., MB BChir – Senior Vice President, Strategy, Alliances and Transactions
Lou Schmukler – President, Technical Operations
Elliott Sigal, M.D., Ph.D. – Executive Vice President, Chief Scientific Officer and President, R&D
Paul von Autenried - Senior Vice President and Chief Information Officer
Board of Directors
James M. Cornelius – Chairman
Lamberto Andreotti - Chief Executive Officer
Lewis B. Campbell – Retired Chairman, Textron Inc.
Louis J. Freeh – Senior Managing Partner, Freeh Group International
Laurie H. Glimcher - Professor of Immunology, Harvard School of Public Health, & Professor of Medicine, Harvard Medical School
Michael Grobstein – Retired Vice Chairman, Ernst & Young
Alan J. Lacy – Senior Advisor, Oak Hill Capital Partners
Vicki L. Sato - Professor of Management Practice, Harvard Business School, and Professor of Molecular & Cell Biology, Harvard University
Elliott Sigal, M.D., Ph.D. – Executive Vice President, Chief Scientific Officer and President, R&D
Togo D. West, Jr. – Chairman, TLI Leadership Group & Noblis, Inc.
R. Sanders Williams – President, Robert W. and Linda L. Mahley Distinguished Professor, The J. David Gladstone Institutes and Professor of Medicine, University of California, San Francisco
——
Bristol-Myers Squibb Company Worldwide Medicines Group
-777 Scudders Mill Road; Plainsboro, NJ 08536 (609) 252-4000 (phone) (609) 252-5360 (fax)
(Same management & board listings as above.)
——
Celgene Corporation
-86 Morris Avenue; Summit, NJ 07901 (908) 673-9000 (phone) (908) 673-9001 (fax)
Management
Robert J. Hugin – President and Chief Executive Officer
Jacqualyn A. Fouse – Senior Vice President and Chief Financial Officer
Perry Karsen – Chief Operations Officer
Board of Directors
Robert J. Hugin – Chairman and Chief Executive Officer
Michael D. Casey – Former President and Chief Executive Officer of Matrix Pharmaceutical, Inc.
Rodman L. Drake – Managing Director CIP Management
Gilla Kaplan, Ph.D. – Professor and Full Member In the Laboratory of Mycobacterial Immunity and Pathogenesis at the Public Health Research Institute Center at UMDNJ
James Loughlin – Former Chairman, Pension and Investment Committee of the KPMG Board
Ernest  Mario, Ph.D. – Former Deputy Chairman and Chief Executive of Glaxo Holdings plc.
Carrie S. Cox – Former Executive Vice President and President of Schering-Plough’s Global Pharmaceutical Business
Michael A.  Friedman, M.D. – President and Chief Executive Officer of the City of Hope
——
CSL Behring, L.L.C.
-1020 1st Avenue; King of Prussia, PA 19406 (610) 878-4000 (phone) (610) 868-3330 (fax)
Management Team
Paul R. Perreault – President, CSL Behring
Alan Anderson – Vice President, Western Europe
Russell Basser – Senior Vice President, Global Clinical Research & Development
Diane Black, PhD – Senior Vice President, Global Quality
Greg Boss – Senior Vice President & CSL Group General Counsel
Wally Casey – Senior Vice President & General Manager, Kankakee Plant
Debbie Drane – Senior Vice President, R&D, ISCOMATRIX ® Adjuvant
Karen Etchberger – Executive Vice President, Plasma, Supply Chain & Information Systems
Randy Furby – Senior Vice President & General Manager, CSL Plasma
Dennis Jackman – Senior Vice President, Public Affairs
Uwe E. Jocham – Senior Vice President & General Manager, CSL Behring AG
Jeannie Joughin – Vice President, Business Development
Roland Martin – Senior Vice President & General Manager, CSL Behring GmbH, Marburg
Karen Neave – Senior Vice President
John A. “Andy” Newsom – Chief Information Officer
Lynne Powell – Senior Vice President, North America Commercial Operations
Val Romberg – Senior Vice President, Research & Development
Dr. Ingolf Sieper – Executive Vice President, Worldwide Commercial Operations
Mary Sontrop – Executive Vice President, CSL Behring Operations
Markus Staempfli – Vice President & General Manager, Intercontinental Commercial Operations
Kiyoaki Yamabe – Vice President & General Manager, CSL Behring K.K.
——
Cubist Pharmaceuticals, Inc.
-65 Hayden Avenue; Lexington, MA 02421 781-860-8660 (phone) 781-240-0256 (fax)
Management
Michael W. Bonney - President and CEO
Steven C. Gilman, Ph.D. - Executive Vice President, Research & Development and Chief Scientific Officer
Timothy D. Hunt, J.D. - Senior Vice President, Public Affairs
Tamara L. Joseph, J.D. - Senior Vice President, General Counsel and Secretary
Charles Laranjeira - Senior Vice President, Technical Operations
David W. J. McGirr, M.B.A. - Senior Vice President and Chief Financial Officer
Robert J. Perez, M.B.A. - Executive Vice President and Chief Operating Officer
Gregory Stea - Senior Vice President, Commercial Operations
Santosh Vetticaden, M.D., Ph.D. - Senior Vice-President, Chief Medical and Development Officer
——
Daiichi Sankyo, Inc.
-Two Hilton Court; Parsippany, NJ 07054 (973) 359-2600 (phone) (973) 359-2645 (fax)
John P. Gargiulo – President and CEO
Glenn J. Gormley, M.D., Ph.D. – Chief Science Officer, Co-Head, Research &
Development
——
Dainippon Sumitomo Pharma Co., Ltd.
-2-6-8 Doshomachi; Chuo-ky, Osaka, Japan 541-0045 81-6-6203-5321 (Phone) 81-6-6203-6581 (Fax)
(See http://www.ds-pharma.com/profile/executive/index.html
^—–v
Sunovion Pharmaceuticals Inc.
-84 Waterford Drive; Marlborough, MA 01752 508-481-6700 (Phone) 508-357-7490 (Fax)
Our Leaders
Mark Iwicki : President and Chief Executive Officer
Richard Russell : Executive Vice President and Chief Commercial Officer
Nobuhiko Tamura : Executive Vice President and Chief Scientific Officer
Saburo Hamanaka : Executive Vice President, Corporate Strategy
Antony Loebel, M.D. : Executive Vice President and Chief Medical Officer
Mark J. Wanda : Senior Vice President, General Counsel and Corporate Secretary
Robert Gregorio : Senior Vice President Human Resources & Administration
——
Depomed, Inc.
-1360 O’Brien Drive; Melon, CA 94025 (650) 462-5900 (phone) (650) 462-9993 (fax)
Management
James A. Schoeneck – President and Chief Executive Officer
William Callahan – Vice President, Operations
Tammy L. Cameron – Vice President, Finance
Jeff Coon – Vice President, Human Resources
Matthew M. Gosling – Senior Vice President and General Counsel
Steve Greco – Vice President, Sales
Gerd Kochendoerfer – Vice President, Pharmaceutical Development
Michael Sweeney, M.D. – Chief Medical Officer and Vice President, Research and Development
Thadd M. Vargas – Senior Vice President, Business Development
Kevin Weber – Vice President, Marketing
Board of Directors
Peter D. Staple – Chief Executive Officer, Corium International, Inc.
Craig R. Smith, M.D. – Chief Operating Officer, Algenol Biofuels, Inc. and President, Williston Consulting, LLC
G. Steven Burrill – Chief Executive Officer, Burrill & Company
Karen A. Dawes – President, Knowledgeable Decisions, LLC
James A. Schoeneck – President and Chief Executive Officer, Depomed, Inc.
Julian N. Stern – Attorney, Heller Ehrman LLP
David B. Zenoff – President, David B. Zenoff and Associates
——
Eisai Inc. (Japanese)
-100 Tice Boulevard; Woodcliff Lake, NJ 07677 (201) 692-1100 (phone) (201) 692-1804 (fax)
Haruo Naito – President and CEO
——
Eli Lilly and Company (See http://fedupusa.wordpress.com/eli-lilly-and-company/)
-Lilly Corporate Center, 893 South Delaware; Indianapolis, IN 46285 (317) 276-2000 (phone) (317) 276-9707 (fax)
Executive Management
John C. Lechleiter, Ph.D. – Chairman, President and Chief Executive Officer
Robert A. Armitage – Senior Vice President and General Counsel
Bryce D. Carmine – Executive Vice President and President, Lilly Bio-Medicines
Enrique Conterno – Senior Vice President and President, Lilly Diabetes
Frank M. Deane, Ph.D. - President, Manufacturing Operations
Stephen F. Fry – Senior Vice President, Human Resources and Diversity
Jan M. Lundberg, Ph.D. – Executive Vice President, Science and Technology, and President, Lilly Research Laboratories
Sue Mahony, Ph.D. – Senior Vice President and President, Lilly Oncology
Anne Nobles - Chief Ethics and Compliance Officer, and Senior Vice President, Enterprise Risk Management 
Bart Peterson – Senior Vice President, Corporate Affairs and Communications
Derica W. Rice – Executive Vice President, Global Services, and Chief Financial Officer
Jeffrey Simmons - Senior Vice President and President, Elanco Animal Health
Jacques Tapiero – Senior Vice President and President, Emerging Markets
Fionnuala M. Walsh, Ph.D. – Senior Vice President, Global Quality
Board of Directors
John C. Lechleiter, Ph.D. – Chairman, President, and Chief Executive Officer, Eli Lilly and Company
Ralph Alvarez – Retired President and Chief Operating Officer, McDonald’s Corporation
Sir Winfried Bischoff – Chairman, Lloyds Banking Group plc
Michael L. Eskew – Former Chairman and Chief Executive Officer, United Parcel Service, Inc.
Martin S. Feldstein, Ph.D. – George F. Baker Professor of Economics, Harvard University
J. Erik Fyrwald – Chairman, President, and Chief Executive Officer, Nalco Company
Alfred G. Gilman, M.D., Ph.D. – Chief Scientific Officer, Cancer Prevention and Research Institute of Texas
R. David Hoover -Chairman, Ball Corporation
Karen N. Horn, Ph.D. – Retired President, Private Client Services, and Managing Director, Marsh, Inc.
Ellen R. Marram – President, The Barnegat Group LLC
Douglas R. Oberhelman – Chairman and Chief Executive Officer, Caterpillar Inc.
Franklyn G. Prendergast, M.D., Ph.D. – Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Professor of Molecular Pharmacology and Experimental Therapeutics, Mayo Medical School; Director, Mayo Clinic Center for Individualized Medicine
Kathi P. Seifert – Retired Executive Vice President, Kimberly-Clark Corporation
Some Former Board Members: George H. W. Bush; Kenneth Lay, former CEO, Enron; William Verity Jr., former U.S. Secretary of Commerce. …
——
EMD Serono 
-One Technology Place; Rockland, MA 02370 (781) 982-9000 (phone) (781) 982-9478 (fax)
(“Website currently unavailable … in 5 seconds we will redirect you to Merck Group.”) 
Endo Pharmaceuticals, Inc.
-100 Endo Boulevard; Chadds Ford, PA 19317 (610) 558-9800 (phone) (610) 558-8979 (fax)
Management
David P. Holveck - President, Chief Executive Officer and a Director
Anthony P. Bihl III – Group President  
Larry Cunningham – Senior Vice President, Human Resources
Ivan Gergel, M.D. – Executive Vice President, Research & Development and Chief Scientific Officer
Kelly Huang, Ph.D. – President of HealthTronics, Inc.
Denise Hudson – Senior Vice President, Enterprise Quality and Supply Chain
Alan G. Levin – Executive Vice President and Chief Financial Officer
Caroline B. Manogue – Executive Vice President, Chief Legal Officer and Secretary  
Julie H. McHugh – Chief Operating Officer
Jon Smollen – Senior Vice President, Compliance and Business Practices
James S. B. Whittenburg – Group President
Board of Directors
ROGER H. KIMMEL – Chairman of the Board
JOHN J. DELUCCA
DAVID P. HOLVECK
NANCY J. HUTSON
MICHAEL HYATT
WILLIAM P. MONTAGUE
DAVID B. NASH
JOSEPH C. SCODARI
WILLIAM F. SPENGLER
Ferring Pharmaceuticals, Inc.
-4 Gatehall Drive, 3rd Floor; Parsippany, NJ  07054 Phone: (973) 796-1600 Fax: (973) 796-1664
Executive Board
Michel L. Pettigrew, President of the Executive Board & Chief Operating Officer, Ferring Group
Michel Pettigrew
Pascal Danglas, Executive Vice President, Clinical and Product Development
Peter Wilden, Chief Financial Officer and Executive Vice President
Jean Duvall, Group General Counsel & Secretary to the Board of Directors
Senior Management
Lars Peter Brunse, Senior Vice President, Technical Operations
Per Cantor, Senior Vice President, Clinical and Non-Clinical R&D
Ralph Diehl, Senior Vice President, Europe East, Middle East & India
Folke Flateland, Senior Vice President, Global Pharmaceutical R&D
Aaron Graff, President & Chief Operating Officer (Ferring Pharmaceuticals Inc.)
Jonathan Grover, Senior Vice President, Global Information Technology
Alan S. Harris, Senior Vice President, Global Projects and Portfolio Management
Joachim Hörig, Senior Vice President, Global Quality Assurance
Marianne Kock, Senior Vice President, Global Regulatory, Information & Pharmacovigilance and Vice Managing Director, IPC Copenhagen
Paul Korner, President FIPCUS & SVP US Development
Edgar PJ Koster, Senior Vice President, Global Operational Management
Edvard Philipson, Vice President, Latin America
Gilles Pluntz, Senior Vice President, Europe West
Pierre Rivière, President, Ferring Research Institute & Senior Vice President, Research
Paul Vibert, Senior Vice-President, Asia Pacific
Bernie Ruszala, Vice President Global Marketing
Board of Directors
Frederik Paulsen - Chairman
Jeffrey D. Hobbs - Vice-Chairman
Alexandra Countess of Frederiksborg
John Patterson
Hélène Ploix
Hans Peter Hasler
Genzyme Corporation
-500 Kendall Square; Cambridge, MA 02142 (617) 252-7500 (phone) (617) 252-7600 (fax)
GlaxoSmithKline
-Five Moore Drive; P.O. Box 13398; Research Triangle Park, NC 27709 (919) 483-2100 (phone) (919) 483-6002 (fax)
Grifols USA, LLC
-79 T.W. Alexander Drive; 4101 Research Commons; Research Triangle Park, NC  27709 919-316-6300 (phone) 919-316-6302 (fax)
Helsinn Therapeutics
-1160 US Highway 22, Suite 104; Bridgewater, NJ  08807 908-203-6548 (phone) 908-575-1978 (fax)
Horizon Pharma, Inc.
-1033 Skokie Boulevard, Suite 355; Northbrook, IL  60062 (224) 383-3000 (phone) (224) 383-3001 (fax)
Ikaria, Inc.
-6 State Route 173; Clinton, NJ  08809 Phone:  908-238-6600 Fax:  908-238-6633
-One Johnson & Johnson Plaza; New Brunswick, NJ 08933 (732) 524-0400 (phone) (732) 214-0332 (fax)
-Four Parkway North, Suite 200; Deerfield, IL 60015 (847) 282-1000 (phone) (847) 282-1001 (fax)
Merck & Co., Inc.
-770 Sumneytown Pike, P. O. Box 4; Whitehouse Station, NJ 08889 (908) 423-1000 (phone) (908) 423-1160 (fax) 
Merck Human Health Division – U.S. Human Health
-51 North Sumneytown Pike; North Wales, PA 19454 (215) 652-5000 (phone) 
Merck Research Laboratories
-770 Sumneytown Pike; West Point, PA 19486 (215) 652-5000 (phone)
Merck Vaccine Division
-770 Sumneytown Pike; West Point, PA 19486 (215) 652-5000 (phone) (215) 993-0884 (fax)
-1 Health Plaza; East Hanover, NJ 07936 (862) 778-8300 (phone) (973) 781-8265 (fax)
-100 College Road West; Princeton, NJ 08540 (609) 987-5800 (phone) (609) 580-2406 (fax)
-3344 North Torrey Pines Ct., Suite 200; La Jolla, CA 92037 858-875-8600 (phone) 858-875-8650 (fax)
-1 University Square Drive; Princeton, NJ 08540 609-452-2922 (phone) 609-452-0795 (fax)
Otsuka Pharmaceuticals Development & Commercialization, Inc. (OPDC)
-2440 Research Boulevard; Rockville, MD 20850 301-990-0030 (phone) 301-212-8647 (fax)
Otsuka Maryland Medicinal Laboratories (OMML)
-2440 Research Boulevard; Rockville, MD 20850 301-990-0030 (phone) 301-212-8647 (fax)
-235 East 42nd Street, 16th Floor; New York, NY 10017 (212) 733-2323 (phone) (212) 573-7851 (fax)
Purdue Pharma L.P.
-One Stamford Forum; Stamford, CT 06901 (203) 588-8000 (phone) (203) 588-8850 (fax)
sanofi-aventis U.S.
-300-400 Somerset Corporate Boulevard; Bridgewater, NJ 08807 (908) 243-6000 (phone) (908) 243-6483 (fax)
sanofi pasteur
-Discovery Drive; Swiftwater, PA 18370 (570) 839-7187 (phone) (570) 839-0955 (fax)
sanofi-aventis
-55 Corporate Drive, 55B-210A; Bridgewater, NJ 08807 (908) 981-6957 (phone) (908) 243-2313 (fax)
Shionogi Inc.
-300 Campus Drive; Florham Park, NJ 07932 (973) 966-6900 (phone)
— 
-9841 Washingtonian Blvd. Suite 500; Gaithersburg, MD 20878 Phone: (301) 948-1041 Fax: (301) 948-2049
-4520 East West Highway, 3rd Floor; Bethesda, MD 20814 United States 301-961-3400 (phone) 301-961-3440 (fax)
-1 Takeda Parkway; Deerfield, IL 60015 (224) 554-6500 (phone)
-901 Gateway Boulevard; South San Francisco, CA 94080 (650) 808-6000 (phone) (650) 827-8690 (fax)
-1110 Spring Street; Silver Spring, MD  20910 Phone:  301-608-9292 Fax:  301-608-9291
Vertex Pharmaceuticals Incorporated
-130 Waverly Street; Cambridge, MA 02139 Tel: 617-444-6100
-106 Allen Road; Basking Ridge, NJ  07920 908-212-1020 (phone) 908- 542-1329 (fax)
-2910 Seventh Street; Berkeley, CA  94710 510-644-1170 (phone) 510-644-0539 (fax)
——

Leave a Comment »

No comments yet.

RSS feed for comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s

Theme: Silver is the New Black. Blog at WordPress.com.

Follow

Get every new post delivered to your Inbox.

Join 34 other followers

%d bloggers like this: